Patent · US Active

5,6-dimethylthieno[2,3-di] pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus

US7816351B2 · kind B2 · utility

2Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2005
Grant dateOct 19, 2010
Priority date
Expiry dateSep 12, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P31/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are 5,β-dimethylthieno[2,3-d]pyrimidine derivatives useful as antiviral agents. More particularly, disclosed are 5,β-dimethylthieno[2,3-djpyrimidine derivatives represented by Formula 1, having an excellent inhibitory effect on the proliferation of hepatitis C virus (HCV), pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition for the prevention and treatment of hepatitis C virus (HCV), containing, as active ingredients, these compounds. The 5,6-dimethylthieno[2,3-d]pyrimidine derivatives represented by Formula 1 have an excellent effect of inhibiting the proliferation of hepatitis C virus and also have low toxicity. Thus, these compounds are available as agents for the prevention and treatment of hepatitis C.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.